EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Development of a New Method Based on Copper Sulfide Nanoparticles for the Determination of Fentanyl in Biological Samples

Sedigheh Mohammadzadeh, Zahra Karimzadeh

ImmunoAnalysis · 2022

DOI: 10.34172/ia.2022.05 ↗
AbstractBibliografische Angaben

Abstract

Background: Fentanyl is an opioid analgesic drug extensively used to alleviate pain with no consciousness loss. To address the fentanyl crisis from the criminal and medical perspectives,the development of a free drug determination methodology for this drug is crucial. Methods: A fluorescent nanoprobe based on copper sulfide nanoparticles (CuS NPs) is developed for the determination of fentanyl in exhaled breath condensate (EBC). NPs are synthesized according to a hydrothermal method and their size and morphology are characterized via X-ray diffraction (XRD), Fourier-transformed infrared (FTIR), and TEM. The fluorescence intensity of the nanoprobe is enhanced in the presence of fentanyl. The affinity of CuS NPs to complex formation with fentanyl results in blocking non-radiative e−/h+recombination defect sites on the surface of NPs and consequently enhancing the signal intensity. One at a time optimization method was used for the optimization of reaction conditions. Results: Under the optimized conditions, a low limit of detection (LOD) of 0.008 µg mL-1 was obtained for fentanyl determination. Furthermore, a linear relationship is found between the analytical response and the concentration of fentanyl in the range of 0.01-2.0 µg mL-1 with a relative standard deviation of

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →